Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 1
2006 1
2007 1
2008 1
2010 4
2011 1
2012 1
2014 2
2016 2
2017 2
2020 1
2021 3
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Protein Kinases in Leukemias.
De Sepulveda P, Pasquet JM. De Sepulveda P, et al. Cancers (Basel). 2021 Jun 1;13(11):2747. doi: 10.3390/cancers13112747. Cancers (Basel). 2021. PMID: 34206000 Free PMC article.
SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis.
Voisset E, Brenet F, Lopez S, de Sepulveda P. Voisset E, et al. Among authors: de sepulveda p. Cancers (Basel). 2020 Jul 21;12(7):1996. doi: 10.3390/cancers12071996. Cancers (Basel). 2020. PMID: 32708273 Free PMC article. Review.
TET2 regulates immune tolerance in chronically activated mast cells.
Rigo R, Chelbi R, Agopian J, Letard S, Griffon A, Ghamlouch H, Vernerey J, Ladopoulos V, Voisset E, De Sepulveda P, Guittard G, Nunès JA, Bidaut G, Göttgens B, Weber M, Bernard OA, Dubreuil P, Soucie E. Rigo R, et al. Among authors: de sepulveda p. JCI Insight. 2022 Apr 8;7(7):e154191. doi: 10.1172/jci.insight.154191. JCI Insight. 2022. PMID: 35393954 Free PMC article.
GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness.
Agopian J, Da Costa Q, Nguyen QV, Scorrano G, Kousteridou P, Yuan M, Chelbi R, Goubard A, Castellano R, Maurizio J, Teodosio C, De Sepulveda P, Asara JM, Orfao A, Hermine O, Dubreuil P, Brenet F. Agopian J, et al. Among authors: de sepulveda p. Blood. 2021 Oct 28;138(17):1590-1602. doi: 10.1182/blood.2020008948. Blood. 2021. PMID: 33974006 Free article.
FES kinase participates in KIT-ligand induced chemotaxis.
Voisset E, Lopez S, Chaix A, Vita M, George C, Dubreuil P, De Sepulveda P. Voisset E, et al. Among authors: de sepulveda p. Biochem Biophys Res Commun. 2010 Feb 26;393(1):174-8. doi: 10.1016/j.bbrc.2010.01.116. Epub 2010 Feb 1. Biochem Biophys Res Commun. 2010. PMID: 20117079
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology.
Hammam K, Saez-Ayala M, Rebuffet E, Gros L, Lopez S, Hajem B, Humbert M, Baudelet E, Audebert S, Betzi S, Lugari A, Combes S, Letard S, Casteran N, Mansfield C, Moussy A, De Sepulveda P, Morelli X, Dubreuil P. Hammam K, et al. Among authors: de sepulveda p. Nat Commun. 2017 Nov 10;8(1):1420. doi: 10.1038/s41467-017-01582-5. Nat Commun. 2017. PMID: 29127277 Free PMC article.
The tumor suppressor activity of SOCS-1.
Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P, de Sepulveda P. Rottapel R, et al. Among authors: de sepulveda p. Oncogene. 2002 Jun 27;21(28):4351-62. doi: 10.1038/sj.onc.1205537. Oncogene. 2002. PMID: 12080466
29 results